Michael Ortiz, MD

Trials

Studies that name Michael Ortiz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:29 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05985161 · A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

  Memorial Sloan Kettering Cancer Center · recruiting · Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors · principal investigator
• Ph1
  NCT04928677 · A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

  Memorial Sloan Kettering Cancer Center · recruiting · Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3) · principal investigator
• Ph2
  NCT04671901 · A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

  Memorial Sloan Kettering Cancer Center · terminated · Solid Tumor, Solid Tumor, Childhood, Solid Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.